Combination sclerostin antibody and zoledronic acid...

Bone 2017 / 08 Vol. 101

Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta

Little, David G., Peacock, Lauren, Mikulec, Kathy, Kneissel, Michaela, Kramer, Ina, Cheng, Tegan L., Schindeler, Aaron, Munns, Craig
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Language:
english
Journal:
Bone
DOI:
10.1016/j.bone.2017.04.016
Date:
August, 2017
File:
PDF, 2.37 MB
english, 2017
Conversion to is in progress
Conversion to is failed